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Materials/methods: The different lattice constants dq for 
quadratic and dh hexagonal minibeam arrangement are 
calculated under the constraint of a homogeneous dose 
distribution (0.95<D/Dtumor<1.07 [3]) in the same treatment 
volume using equal initial beam sizes. 
For a fictitious tumor in 10-15 cm depth, both minibeam 
scenarios (initial beam size σ=200µm) are simulated and 
normalized to the SOBP depth dose profile of the 
corresponding broad beam irradiation. The resulting depth 
and spatial dose distributions are used to approximate the 
mean cell survival at a tumor dose of 60 Gy for comparison of 
the two minibeam modes and the homogeneous irradiation. 
Results: While homogeneous irradiation leads to significant 
mean cell death, minibeam irradiation spares up to ~85% of 
the healthy tissue, especially in the superficial tissues. 
For a hexagonal alignment, the lattice constants dh can be 
increased by a factor of 1.144 in comparison to the quadratic 
lattice constant dq. This improves tissue sparing additionally 
by a few percent compared to the square arrangement.  
Conclusion: These results confirm again that proton 
minibeam radiotherapy reduces side effects compared to 
conventional broad beam irradiation. A small additional 
positive effect can be achieved by a hexagonal alignment of 
the minibeams instead of the previously used quadratic 
lattice. Nevertheless, both arrangements make minibeam 
radiotherapy an attractive new approach for clinical proton 
and/or heavy ion therapy. 
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Charged Particle Therapy (CPT) is an effective tool for cancer 
treatment that exploits the high localization of the charged 
ions incoming radiation dose deposition to increase the 
cancer cell death induction while sparing the surrounding 
Organs At Risk. Besides protons, currently the most common 
ion beam type in clinical centers, there has been recently a 
growing interest in heavier ions beams (He, C, O) due to their 
increased Radio Biological Effectiveness, reduced multiple 
scattering and Oxygen Enhancement Ratio, in spite of the 
presence of nuclear fragmentation. Online monitoring of the 
deposited dose range, currently missing in clinical practice, 
would substantially improve the CPT Quality Control: the high 
dose deposition conformity requires an improved control of 
the beam settings to avoid any potential harm resulting from 
patient mis-positioning and biological / anatomical changes 
occurred between the CT scan acquisition and the treatment.  
Dose Monitoring in CPT [1] is performed using the secondary 
radiation produced by the interaction of the beam inside the 
patient body. The study and precise characterization of such 
radiation (beta+, prompt gamma, charged fragments) is the 
cornerstone of any R&D activity aiming for online monitoring 
development. In this contribution we present the 
measurements of the secondary radiation generated by He, C 
and O beams of therapeutic energies, impinging on a beam 
stopping PMMA target collected at the Heidelberg Ion-beam 
Therapy center (HIT).  
The experimental setup, as well as the analysis strategies 
will be reviewed. The detected particle fluxes, as a function 
of the emission angle with respect to the beam direction, 
and the spatial emission distributions will be presented and 
compared to other available measurements [2,3,4,5,6]. 
The implications for dose monitoring applications will be 
discussed, in the context of the current (or planned) state-of-
the-art detector solutions. 
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Purpose: Reducing PET scanning times and radiation exposure 
while improving image quality and quantitative accuracy 
requires detectors with better detection efficiency, spatial 
resolution, and time resolution. Digital photon counter (DPC) 
arrays are fully digital, solid-state single-photon sensors. DPC 
arrays are almost transparent to 511 keV gamma quanta, 
opening up new degrees of freedom in PET detector design.  
This work compares the detector performance of monolithic 
LYSO:Ce crystals read out with DPC arrays in so-called dual-
sided readout (DSR) configuration and conventional back-side 
readout (BSR). Moreover, first imaging results are presented 
with BSR monolithic scintillators in a setup representative of 
a 70 cm diameter clinical TOF-PET scanner.  
Materials and Methods: DPC arrays consisting of 8 x 8 DPC 
pixels and having a total area of 32 mm x 32 mm were 
optically coupled to commercially available, standard-grade 
LYSO:Ce crystals having dimensions of 32 mm x 32 mm x 22 
mm. Either a single DPC array was coupled to the 32 mm x 32 
mm back surface of the crystal (BSR configuration) or DPC 
